Cardiac diseases in AIDS epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 2: Line 2:
{{Cardiac diseases in AIDS}}
{{Cardiac diseases in AIDS}}
{{CMG}}; {{AE}} {{RT}}
{{CMG}}; {{AE}} {{RT}}
==Overview==
Incidence of many cardiovascular diseases has reduced after the induction of anti-retroviral therapy in the treatment of HIV infection.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
Incidence of many cardiovascular diseases reduced after the induction of anti-retroviral therapy in the treatment of HIV infection. Before the introduction of HAART the incidence of various cardiovascular diseases was as follows:
Before the introduction of HAART the incidence of various cardiovascular diseases was as follows:
* [[Dilated cardiomyopathy]] - 1590 per 100,000
* [[Dilated cardiomyopathy]] - 1590 per 100,000
* [[Systemic hypertension]] - 20,000 - 25,000 per 100,000. After the introduction of HAART the incidence increased significantly to 74,000 per 100,000 <ref name="pmid11600829">{{cite journal |author=Sattler FR, Qian D, Louie S, ''et al.'' |title=Elevated blood pressure in subjects with lipodystrophy |journal=[[AIDS (London, England)]] |volume=15 |issue=15 |pages=2001–10 |year=2001 |month=October |pmid=11600829 |doi= |url=}}</ref>.
* [[Systemic hypertension]] - 20,000 - 25,000 per 100,000. After the introduction of HAART the incidence increased significantly to 74,000 per 100,000 <ref name="pmid11600829">{{cite journal |author=Sattler FR, Qian D, Louie S, ''et al.'' |title=Elevated blood pressure in subjects with lipodystrophy |journal=[[AIDS (London, England)]] |volume=15 |issue=15 |pages=2001–10 |year=2001 |month=October |pmid=11600829 |doi= |url=}}</ref>.

Revision as of 17:04, 5 July 2013

Cardiac diseases in AIDS Microchapters

Home

Overview

Pathophysiology

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cardiac diseases in AIDS epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Cardiac diseases in AIDS epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac diseases in AIDS epidemiology and demographics

CDC on Cardiac diseases in AIDS epidemiology and demographics

Cardiac diseases in AIDS epidemiology and demographics in the news

Blogs on Cardiac diseases in AIDS epidemiology and demographics

Directions to Hospitals Treating Cardiac diseases in AIDS

Risk calculators and risk factors for Cardiac diseases in AIDS epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

Incidence of many cardiovascular diseases has reduced after the induction of anti-retroviral therapy in the treatment of HIV infection.

Epidemiology and Demographics

Incidence

Before the introduction of HAART the incidence of various cardiovascular diseases was as follows:

References

  1. Sattler FR, Qian D, Louie S; et al. (2001). "Elevated blood pressure in subjects with lipodystrophy". AIDS (London, England). 15 (15): 2001–10. PMID 11600829. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources